In order to understand the potential of anti‐macrophage therapy concerning blood vessel function and glioma progression, we inhibited macrophage recruitment in the tumor microenvironment using anti‐CSF1 monoclonal antibody treatment. This evidence concerns the gene CSF1 and neoplasm.